KYTX

Kyverna Therapeutics (KYTX)

About Kyverna Therapeutics (KYTX)

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Details

Daily high

$11.44

Daily low

$9.96

Price at open

$10.70

52 Week High

$13.67

52 Week Low

$1.78

Market cap

473.9M

Dividend yield

0.00%

Volume

2.0M

Avg. volume

1.5M

P/E ratio

-2.91

Kyverna Therapeutics News